Your browser doesn't support javascript.
loading
Should we customize the treatment with interleukin-17A inhibitors for moderate-to-severe psoriasis in the real-world setting?
Hu, Kun; Zhang, Mi; Yang, Jing; Wang, Qiaolin; Tan, Minjia; Deng, Sichun; Chen, Junchen; Zhu, Wu; Chen, Wendong; Kuang, Yehong; Chen, Xiang.
Afiliação
  • Hu K; Department of dermatology, Xiangya Hospital of Central South University, Changsha, China.
  • Zhang M; Department of dermatology, Xiangya Hospital of Central South University, Changsha, China.
  • Yang J; Department of dermatology, Xiangya Hospital of Central South University, Changsha, China.
  • Wang Q; Department of dermatology, Xiangya Hospital of Central South University, Changsha, China.
  • Tan M; Department of dermatology, Xiangya Hospital of Central South University, Changsha, China.
  • Deng S; Department of dermatology, Xiangya Hospital of Central South University, Changsha, China.
  • Chen J; Department of dermatology, Xiangya Hospital of Central South University, Changsha, China.
  • Zhu W; Department of dermatology, Xiangya Hospital of Central South University, Changsha, China.
  • Chen W; Normin Health Consulting Ltd, Toronto, Canada.
  • Kuang Y; Department of dermatology, Xiangya Hospital of Central South University, Changsha, China.
  • Chen X; Department of dermatology, Xiangya Hospital of Central South University, Changsha, China.
J Eur Acad Dermatol Venereol ; 37(2): e262-e263, 2023 02.
Article em En | MEDLINE | ID: mdl-36268702
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Psoríase / Inibidores de Interleucina Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Psoríase / Inibidores de Interleucina Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article